Detailed View
LXEO - Lexeo Therapeutics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
372,977,760
Adj EBIT (TTM)
-97,785,000
Enterprise Value
301,935,760
Last Price
4.75
Earnings Yield
-32.39%
Return on Capital
-41.41%
Capital
236,167,000
1Y Price Chart
Last Price: $4.75
1Y Change: 21.17%
As of 2026-06-16 | 1Y Change: 21.17%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -22,333,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -23,116,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -21,648,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -30,688,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -33,805,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -27,382,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -31,543,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -23,550,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.